
==== Front
Sao Paulo Med J
Sao Paulo Med J
Sao Paulo Med J
São Paulo Medical Journal
1516-3180
1806-9460
Associação Paulista de Medicina - APM

15160524
10.1590/S1516-31802004000100007
Review Article
Pulmonary alterations in cocaine users
Alterações pulmonares em usuários de cocaínaMário Terra Filho *
Chen Chin Yen *
Ubiratan de Paula Santos *
Muñoz Daniel Romero *
Address for correspondence : Mário Terra Filho Faculdade de Medicina da Universidade de São Paulo Instituto do Coração — Hospital das Clínicas Disciplina de Pneumologia Av. Dr. Enéas de Carvalho Aguiar, 44 5o andar — bloco 2 — Cerqueira César São Paulo/SP — Brasil — CEP 05403-000 Tel. (+55 11) 3069-5695 Fax (+55 11) 3082-7040 E-mail: pnemario@incor.usp.br
Conflict of interest: Not declared

08 1 2004
2004
122 1 2631
09 9 2000
07 2 2003
15 7 2003
https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons license.
ABSTRACT

CONTEXT:

Brazilian researchers have recently recognized a marked increase in the number of people using abusable drugs and the consequences of this habit. It has become a major public health problem in a potentially productive segment of the general population. In the last few years, several medical articles have given special emphasis to pulmonary complications related to cocaine use. This review is based on this information and experience acquired with groups of cocaine users.

OBJECTIVE:

To present to physicians the pulmonary aspects of cocaine use and warn about the various effects this drug has on the respiratory system, stressing those related to long-term use.

DESIGN:

Narrative review.

METHOD:

Pulmonary complications are described. These may include infections (Staphylococcus aureus, pulmonary tuberculosis, acquired immunodeficiency syndrome/aids, etc.), aspiration pneumonia, lung abscess, empyema, septic embolism, non-cardiogenic pulmonary edema, barotrauma, pulmonary granulomatosis, bronchiolitis obliterans and organizing pneumonia, pneumonitis and interstitial fibrosis, pneumonitis hypersensitivity, lung infiltrates and eosinophilia in individuals with bronchial hyperreactivity, diffuse alveolar hemorrhage, vasculitis, pulmonary infarction, pulmonary hypertension and alterations in gas exchange. It is concluded that physicians should give special attention to the various pulmonary and clinical manifestations related to cocaine use, particularly in young patients.

RESUMO

CONTEXTO:

Recentemente, os pesquisadores brasileiros reconheceram que o número de pessoas que utilizam drogas de abuso e as conseqüências decorrentes desse hábito aumentaram consideravelmente, constituindo, hoje, um dos maiores problemas de saúde pública abrangendo uma camada de população potencialmente produtiva. Nos últimos anos, vários artigos médicos têm dado especial ênfase às complicações pulmonares relacionados ao uso de cocaína nos seus usuários. Com base nessas informações e na experiência adquirida com grupos de usuários de cocaína, redigimos esta revisão com o intuito de alertar a classe médica quanto aos diferentes efeitos no sistema respiratório.

OBJETIVO:

Apresentar aos médicos os aspectos pulmonares envolvidos com o uso da cocaína e alertálos quanto aos diversos efeitos dessa droga sobre o aparelho respiratório, ressaltando aqueles relacionados com o uso a longo prazo.

TIPO DE ESTUDO:

Revisão narrativa.

MÉTODO:

São descritas complicações pulmonares, tais como, infecções (Staphylococcus aureus, tuberculose pulmonar e extrapulmonar, síndrome da imunodeficiência adquirida, aids, etc.), pneumonia aspirativa, abscesso pulmonar, empiema, embolia séptica, edema pulmonar nãocardiogênico, barotrauma, granulomatose pulmonar, bronquiolite obliterante com pneumonia em organização, pneumonite e fibrose intersticial, pneumonite por hipersensibilidade, infiltrados pulmonares e eosinofilia em pessoas com hiper-reatividade brônquica, hemorragia alveolar difusa, vasculite, enfarto pulmonar, hipertensão pulmonar e alterações de troca gasosa. Assim, é necessário que os médicos atentem, hoje em dia, na sua rotina diária, para as diversas complicações pulmonares e manifestações clínicas associados ao uso de cocaína, particularmente nos jovens.

KEY WORDS:

Crack cocaine
Drug abuse
Dependency
Cocaine
Lung
PALAVRAS-CHAVE:

Cocaína crack
Cocaína
Drogas de abuso
Abuso de cocaína
Transtornos relacionados ao uso de cocaína
Dependência de cocaína
==== Body
pmcINTRODUCTION

An illicit drug can be defined as any substance that is forbidden or not authorized by law and society's rules. Drug abuse refers to the consumption of licit or illicit drugs in order to attain an altered mental state.1 Thus, a drug is considered to be an abusable drug when it can be used for non-medical purposes and leads to addiction (compulsive use, loss of control over consumption and continued use in spite of social, economic or medical consequences). According to the World Health Organization (WHO), drug dependence corresponds to "the mental state, and often a physical state, resulting from the interaction between a living organism and a drug". It is characterized by behavior that always includes the compulsion to take the drug in order to experience its psychic effect and sometimes to avoid the discomfort of its absence.2

Drug abuse has reached considerable proportions in the last few years,3 and currently ranks as a major public health problem. The use of illegal drugs has spread to potentially productive segments of the general population, predominantly young4 adult men.5-7 In Brazil, surveys carried out by Cebrid (Brazilian Information Center on Psychotropic Drugs),8,9 Grea (Interdisciplinary Study Group on Alcohol and Drugs)10 and Denarc (State Department of Narcotics Investigations)11 have shown increasing consumption of such drugs, particularly of cocaine. In other studies involving Brazilian students,12,13 it was shown that 90% of the participants had already tried some illegal drug at least once, such drugs were predominantly used by men and consumption of abusable drugs had begun at an early age, around 10-12 years old.14 Among the abusable drugs, alcohol, marijuana and cocaine are the ones most consumed worldwide, in the salt or base forms.14,15 Most users take them simultaneously or report previous use of other drugs. In general, cocaine is used with alcohol.7,16-19 Interaction between alcohol and cocaine results in the formation of cocaethylene,20 which can increase the effects and toxicity of cocaine.16 Some authors have reported that ethanol and cocaine association increases the risk of sudden death.21, 22

Muñoz et al.23 studied the use of alcohol, marijuana and cocaine in 63 victims of violent death in the city of Guarulhos (state of São Paulo, Brazil). Blood and urine samples obtained during autopsy were used in the study, and 61.9% of the victims were positive for the three drugs. Alcohol was detected in 53.33%, cocaine or its metabolites were found in 25.86% and cannabinoids in 17.24% of the cases. In an analysis of hair samples from 38 victims of the same group with positive results for cocaine in urine, Toledo et al.24 found this drug or its metabolite (benzoylecgonine) in all samples.

Cocaine is an alkaloid found in the leaves of Erythroxylon coca, commonly known as coca, a native plant of the Andean and Amazon regions in South America. It was first extracted and identified by the German chemist Albert Niemann in the mid-19th century.25 The inhabitants of the Andes chewed the leaves to ward off fatigue, hunger and thirst, to enhance endurance, and to promote a sense of wellbeing. Because of its pharmacological properties, it had medical use as a tonic/elixir for several diseases and also as local anesthetic in eye, ear and throat surgery.1 It was subsequently replaced by synthetic anesthetics such as lidocaine.26 Cocaine was also used in popular beverages and the most popular of these were Vin Mariani and Coca-Cola in its original formulation.1 It has no therapeutic indication today and its importance derives from being considered to be an abusable drug.

Cocaine is a powerful central nervous system stimulant and has very complex activity, both through central and peripheral pathways. Its anesthetic effect is achieved by blocking sodium influx in the nerve cell membrane, thereby preventing nervous transmission.25,27,28 It is assumed that alterations in dopamine transport are the mechanism for the euphoric and compulsive effects of cocaine.29-33

This illicit drug is sold on the street, mixed with similar-looking substances like lidocaine, talcum powder or sugar. Cocaine is generally consumed in freebase form or smoked as "crack". It can be absorbed via intranasal, intravenous or vaginal routes in the hydrochloride form or by massaging the gums in coca paste form (prepared using solvents like kerosene and gasoline). It can be smoked either in pipes or cigarettes.1

"Crack"34,35 was developed in the second half of the 1980s, when the characteristics of cocaine were altered so that it could be smoked. Crack is prepared by heating and evaporating the hydrochloride with a base (generally sodium bicarbonate). After cooling, irregular crystals or "rocks" are the final result. These produce a cracking sound when heated.33,36 Thus, it became known as "crack"5 and has become the most popular form for consumption of this drug. Cocaine obtained by this process may be 100% pure, but the purity can be as low as 20% because contaminants are not always removed and the drug is often further adulterated by the producer.6

Pulmonary effects of cocaine

There are several organic consequences (Table 1) resulting from the chronic use of cocaine by different administration routes and its local or systemic pharmacological effects. Among these are adverse effects on the lungs.37 Respiratory system alterations depend not only on the administration route, but also on the dose and time of use, presence of microbiological contaminants or substances used to adulterate the sample, sharing of paraphernalia used for the drug consumption and host responses of the individual user.38 Small doses of cocaine cause acute respiratory stimulation and large doses lead to respiratory depression. In some users, however, cocaine can promote an undesirable paradoxical effect with an initial increase in respiratory rate and depth followed by depression.2

Table 1 Pulmonary effects of cocaine

Acute respiratory symptoms	
Barotrauma and bullous emphysema	
Pulmonary edema	
Pulmonary hypersensitivity reaction (bronchospasm)	
Alveolar hemorrhage	
Alveolitis, pneumonitis and interstitial fibrosis	
Bronchiolitis obliterans with organizing pneumonia	
Vasculitis and pulmonary hypertension	

When crack is smoked, the lungs are directly exposed to the volatile drug and to the products resulting from its combustion. Rapidly absorbed by the mucous membrane and alveolar epithelium, the drug reaches the bloodstream almost immediately, providing the user with a more rapid and intensive physiological and psychological effect than is obtained by intravenous injection.32,39

Smoking cocaine can produce acute lung injury, and several hypotheses have been proposed to explain this. These include cell anoxia resulting from the cocaine-induced lung vasoconstriction; direct toxic effect on the alveolar capillary endothelium and bronchial epithelium; and hypersensitivity reaction to basic cocaine components.33,36,40

Several pulmonary complications related to cocaine use (Table 2) and administration route have been reported in the literature. Opportunistic and secondary systemic infections with pulmonary involvement have been reported (Staphylococcus aureus, pulmonary tuberculosis or aids33,41 due to poor cleaning of the paraphernalia used),33 aspiration pneumonia and lung abscess, empyema and pulmonary granulomatosis.6,42-44 Thrombophlebitis and septic endocarditis with release of emboli, septic emboli, pulmonary artery obstruction, mycotic aneurysms (pulmonary artery) and lung infiltrates have been described in relation to intravenous cocaine use.38

Table 2 Pulmonary histopathology features related to cocaine use*

Alveolar		
	Pulmonary edema	
	Focal hemorrhages	
	Intact alveolar erythrocytes	
	Macrophages with hemosiderin	
	Foreign material in the alveoli	
	Thickening of the alveoli walls (pneumoconiosis-like)	
	Type II pneumocyte hyperplasia	
	Blebs	
	Emphysema	
Bronchiolar		
	Bronchiolitis obliterans and organizing pneumonia	
Bronchial		
	Alterations of the bronchial epithelium	
	Thickening of the bronchial wall	
	Bronchitis	
Interstitial		
	Granuloma of the giant cell type (injection)	
	Birefringent crystals in the macrophage (around vessels or airways)	
	Interstitial fibrosis	
Vascular		
	Vascular bullous (injection)	
	Septic emboli (injection)	
* According to the literature.38,53,75,76,77

Barotrauma and bullous emphysema

Pneumothorax and pneumomediastinum1,38,45-48 are commonly related to cocaine inshalation or smoking, in the freebase or crack forms. These complications result from coughing or intense Valsalva's maneuver performed to heighten the effect of the drug, thereby leading to a sudden increase in intrabronchial and intraalveolar pressure with subsequent alveolar rupture and air penetration in the pulmonary interstitium.41 The free air can dissect the peribronchial connective tissue in the mediastinum, pericardium, pleural cavity and subcutaneous tissues, resulting in pneumopericardium48 and subcutaneous emphysema.49 Gurney and Bates50 reported the occurrence of bullous emphysema in 10 drug users: they were all young, smokers (3 of them for less than 3 years), with normal alpha-1 antitrypsin serum levels.

Pulmonary edema and immune-mediated pulmonary disease

Reports in the literature describe noncardiogenic pulmonary edema in cocaine users, especially after crack smoking38,51-53 Although the precise mechanism is unclear, some authors believe that there is a relationship with increased lung capillary permeability, since bronchoalveolar lavage fluid from cocaine users has shown increased protein concentration.51

There are reports53-55 in the literature suggesting that crack users can develop pulmonary hypersensitivity reaction with bronchospasm exacerbation.

Alveolar hemorrhage

Alveolar hemorrhage has been described in the last ten years as one of the pulmonary complications caused by cocaine use.38,41,56-58 In 1988, Murray et al.59 reported the first case of alveolar hemorrhage and hypoxemic respiratory failure associated with freebase cocaine smoking, and open-chest biopsy revealed diffuse alveolar hemorrhage. The two cases published by Bouchi et al.60 had hemoptysis and dyspnea symptoms, and alveolar hemorrhage was seen via bronchoscopy as blood originating from the bronchial openings, and via bronchoalveolar lavage as hemosiderin in alveolar macrophages. This last paper suggested that cell damage caused by pulmonary vasoconstriction and alveolar cells caused directly by the drug are the two mechanisms that could possibly trigger hemorrhage.60

In reviewing histopathological lung sections obtained during the necropsy of 52 cadavers with positive toxicological tests for cocaine (equal to or higher than 0.01 mg/dl) in blood, urine or bile, Bailey et al.61 found both acute and chronic alveolar hemorrhage (58 and 40% of the cases, respectively), pulmonary vascular congestion (88%), alveolar edema (77%) and foreign material and microgranulomas (11%).

Alveolitis, pneumonitis and interstitial fibrosis

Ongoing use of cocaine by inhalation can lead to pneumonitis62 and interstitial fibrosis.41,52,53,62 In their histopathological study, Bailey et al.61 found pneumonitis characterized by thickening of the alveolar septum and infiltrate of neutrophils, lymphocytes, macrophages, and eosinophils, and interstitial fibrosis evidenced by type II pneumocyte hyperplasia.

Other authors63 found extensive interstitial inflammatory infiltrate in the lungs of 14 out of 17 forensic necropsies performed on drug users. Their other findings were acute inflammatory alterations of alveolar walls with the presence of exsudate and cells in the alveoli, and vascular obstruction possibly caused by injection of mixtures for oral use (intravenous injection of adulterated cocaine). According to Oubeid et al.,44 talcum powder is the agent most often used to adulterate the drug and this can cause pulmonary fibrosis.

Bronchiolitis obliterans with organizing pneumonia

Reports in the literature accept that the bronchiolitis obliterans with organizing pneumonia observed in some freebase cocaine users may be the result of a direct toxic effect of the drug on the airways.41,49,64 It is also suggested that bronchiolitis obliterans with organizing pneumonia can occur as an idiopathic response to cocaine or substances used in its adulteration, or even from contaminants found in the paraphernalia used for smoking cocaine.64

Vasculitis and pulmonary hypertension

Vasculitis associated with abusable drugs is well-documented in the literature, and some reports have described it as necrotizing vasculitis65 that is similar to polyarteritis nodosa.66 The mechanism by which cocaine causes vascular pathology remains unknown, but it has been associated with cerebral vasculitis.67-70

Although there is mention in the literature that long-term use of intravenous cocaine is associated with pulmonary hypertension, very few cases have been reported and effectively proven.42,71-74 Yakel and Eisenberg71 used transthoracic echocardiography to estimate the pulmonary artery pressure in 13 asymptomatic long-term users of intravenous cocaine, aged between 20 and 45 years, and obtained high pulmonary artery pressure (over 30 mmHg) in eight of these subjects. It is believed that such a pressure increase may be due to a reduction in the pulmonary vascular bed caused by the granulomatous process44 that results from the addition of insoluble agents to the illicit drug (especially talcum powder, cellulose and starch). These agents generate a local chronic interstitial inflammatory process or microembolization in pulmonary arterioles and capillaries.

Clinical manifestations

The respiratory symptoms are varied and are either nonspecific or directly related to the pulmonary disease (Table 3). According to the literature, respiratory symptoms may appear a couple of hours after cocaine use, although in some cases they may occur within a few minutes. The most common clinical complaints related to lung involvement are chest pain41-47 (pleuritic or non-pleuritic); dyspnea;46,47,53,57,64,77,78 cough6,34 with expectoration of dark material (inhalation of residual combustion products) or blood material; hemoptysis42,53,57,64,77 (diffuse alveolar hemorrhage);41,57 fever;47,53,79 and asthma and recurring bronchospasm episodes (exacerbated or non-exacerbated).41,49,54,55 Such symptoms have been reported mainly among crack users6,80 and not with inhalation or intravenous use of cocaine. According to Suhl and Gorelick81 and Delbono et al.,82 the prevalence of such symptoms is highly variable: cough was reported in 26% and 61%, and dyspnea in 21% and 44%.

Table 3 Clinical manifestations related to cocaine*

Chest pain	
Dyspnea	
Cough	
Hemoptysis	
Fever	
Bronchospasm	
* Mainly in "crack" users.

Pulmonary function tests

There are very few studies related to pulmonary function in cocaine users. A study performed in 1987 indicated that smoking cocaine could modify the forced expiratory flow.77 Later studies, however, involving long-term cocaine users smoking freebase, showed spirometry with normal results in most of them,40,81,83 with no evidence of obstructive or restrictive processes and association with nonspecific airway hyper-reactivity.80

Only three of the several studies among crack users have shown decreased carbon monoxide diffusion capacity.40,83,84 The authors of these studies even considered the possibility that this alteration could be related to the alveolar-capillary membrane or pulmonary vasculature lesion. Tashkin et al.,77 on the other hand, did not observe any diffusion alteration among a cohort of 16 cocaine smokers (moderate users), who also used marijuana but did not use tobacco and/or intravenous drugs. According to Tashkin, in another paper published later, discrepancies in the diffusing capacity observed in other studies may be due to sample size; frequency, intensity or duration of cocaine smoking; effects from other drugs smoked; complications resulting from the use of intravenous drugs; or characteristics of the crack users themselves.85

Recently, Goldbaum et al.86 performed a study in Brazil on pulmonary function in 28 cocaine users, all male, with ages ranging from 18 to 50 years. Four of the subjects were also tobacco users and 24 mentioned marijuana and tobacco use. All subjects had respiratory symptoms (cough, expectoration of dark sputum, wheezing and dyspnea) during or after cocaine use, and had normal chest radiographs. One man presented micronodules and septal thickening compatible with respiratory bronchiolitis via high-resolution computed tomography scan. The spirometry values were normal, but mild alterations in carbon monoxide diffusing capacity (60-80% of predicted value) were detected in 7 subjects. The results obtained in that study are compatible with others in the literature.

Radiological findings

The radiological findings reported among cocaine users include atelectasis,47 alveolar opacification (alveolar hemorrhage)38,59 that can regress within a week,41 bilateral interstitial and alveolar infiltrates51,52 (noncardiogenic pulmonary edema), transient53 pulmonary infiltrates,79 pneumonia, pulmonary nodules,64 interstitial infiltrate and fibrosis. In crack users, however, the radiological abnormalities usually described are pneumothorax and pneumomediastinum.48,78 Pneumopericardium,48,87 hemopneumothorax47 and bullous emphysema50 (intravenous administration) have also been reported, especially in the upper lobes.

Chest computerized tomography (CT scan)

Yen et al.88 described computed tomography scan and pathological findings from three patients who were tobacco smokers and frequent users of marijuana and especially cocaine (powder and/or crack). Their radiography was normal but high-resolution computed tomography scan showed a pattern suggesting septal thickening and diffuse micronodules. Pathological findings of transbronchial biopsy were compatible with desquamative pneumonia associated with respiratory bronchiolitis. On the basis of the clinical history and computed tomography and pathological findings, the authors suggest that the use of cocaine, marijuana and/or tobacco in association can cause pulmonary alterations that may progress with long-term illicit use.88

Scintigraphy

To evaluate the alveolar-capillary membrane integrity among crack users, Susskind et al.89 used lung clearance with 99mTc-labeled DTPA (diethylenetriamine pentaacetic acid) in 23 subjects: seven used only crack, seven were tobacco and crack users, and nine used crack and marijuana simultaneously. The authors believe that the pulmonary epithelium lesion and consequent increase in lung permeability result from the direct action of crack vapors or pyrolysis products and the release of inflammatory mediators by effector or structural cells exposed to smoking.89 However, Tashkin et al.90 reported different results in another study. They believe that discrepancies found between the two studies are due to the previous smoking history and other exposure characteristics in the two populations of crack smokers studied.90

Terra-Filho et al.91 studied Ga-67 lung scintigraphy in a group of 26 tobacco smokers, all with a history of illicit drug use (cocaine or cocaine and marijuana) and 22 reporting simultaneous use of marijuana and cocaine. The Ga-67 scintigraphy was positive in eight subjects, but lung parenchyma uptake in the control group subjects (tobacco smokers) was negative. Both groups had normal chest X-rays. The authors believe that the alterations in the Ga-67 scintigraphy studies detected in the illicit drug user group suggest lung inflammatory disease preceding the X-ray abnormalities.91

Bronchoalveolar lavage and sputum

In analyses of bronchoalveolar lavage among cocaine smokers, several authors have reported the presence of large numbers of eosinophils, Charcot-Leyden crystals,38 and larger populations of alveolar macrophages, often containing hemosiderin, and increased protein concentrations38,79 (higher than in congestive heart failure),51 which were greater than what was found in bronchoalveolar lavage among subjects that did not use this drug92 According to the same authors, these findings would represent not only higher alveolar epithelium permeability38,51 but also probable interstitial alveolar inflammatory response to the aggression to the lungs from the drug64,92

Other reports36,93,94 mention that the alveolar macrophages recovered produced fewer inflammatory cytokines such as IL-6, IL-8 and tumor necrosis factor alpha, but produced larger amounts of the immunosuppressor factor TGF-beta (transforming growth factor beta) than from macrophages from non-cocaine smokers.36 This indicates that chronic use of cocaine can limit lung response, thus making the user more susceptible to infections.

CONCLUSION

Whatever the form and administration route used, cocaine causes deleterious effects in the lungs. The respiratory symptoms are not specific, but carbonaceous sputum (dark material) is a characteristic of crack cocaine users. For the majority of long-term addicted subjects, pulmonary function tests show normal results with no evidence of obstructive or restrictive disturbances, but it is possible to identify pulmonary hypersensitivity reaction (bronchospasm) from such procedures when associated with clinical signs. Radiological findings are very important for establishing diagnosis of pulmonary complications in cocaine users (alveolar hemorrhage, pulmonary edema and fibrosis) and crack addicts (pneumothorax and/or pneumomediastinum). High-resolution computed tomography increases the sensitivity for detection of interstitial fibrosis, pneumonitis, alveolitis and bronchiolitis obliterans with organizing pneumonia, but the cost will restrict its use to individual cases with specific complaints. The principal noninvasive technique for investigating pulmonary hypertension is echocardiography. Scintigraphic evaluation of illicit drug users is expensive and is used only for academic purposes. Nowadays, bronchoalveolar lavage is used as a clinical tool for evaluating cocaine users only to rule out other diagnoses, and for research.

The diagnosis of illicit drug-induced lung disease may be difficult if an accurate history of drug use is not obtained. Establishing the diagnosis of drug-induced lung disease is important, because the appropriate treatment may also include referral to drug counseling or rehabilitation.

Mário Terra Filho, MD. Associate Professor, Division of Pulmonary Diseases, Instituto do Coração – Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.

Chen Chin Yen – Deceased. Former Assistant Professor, Division of Pulmonary Diseases, Instituto do Coração – Hospital das Clínicas and Laboratório de Investigação Médica (LIM – 40) da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.

Ubiratan de Paula Santos, MD. Assistant Professor, Division of Pulmonary Diseases, Instituto do Coração – Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.

Daniel Romero Muñoz, MD. Associate Professor, Department of Legal Medicine, Laboratório de Investigação Médica (LIM – 40) da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.

Sources of funding: Not declared

Place where the manuscript was produced: Division of Respiratory Diseases, Instituto do Coração and Laboratório de Investigação Médica (LIM – 40) (Department of Legal Medicine), Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil

Division of Pulmonary Diseases, Instituto do Coração and Laboratório de Investigação Médica (LIM-40), Department of Legal Medicine, Faculdade de Medicina, Universidade de São Paulo, Brasil
==== Refs
REFERENCES

1. Wetli CV Illicit drug abuse Craighead JE Pathology of Environmental and Occupational Disease New York Mosby 1995 259 268
2. O'Brien CP Drug addiction or drug abuseIn: Hardman JG Limbird LE Goodman & Gilman's The Pharmacological Basis of Therapeutics New York McGraw-Hill 1996 557 577
3. Bastos FIM Lopes CS Dias PRTP Lima ES Oliveira SB Luz TP Perfil de usuários de drogas I: Estudo de características de pacientes do NEPAD/UERJ - 1986/1987 [Profile of drug users: Study I. of characteristics of patients attended at NEPAD/UERJ - 1986/1987] Rev ABP-APAL 1988 10 2 47 52
4. Rojas GE Castro ME Serna JJ Garcia G. Análisis regional sobre el uso de drogas en la población estudantil del Mexico. [Regional analysis of drug use in the Mexican student population] Salud Publica Mex 1987 29 4 331 344 3672226
5. Nappo SA Galduróz JCF Noto AR Uso do "crack" em São Paulo: fenômeno emergente? [Crack use in São Paulo city: an emergent phenomenon?] Rev ABP-APAL 1994 16 2 75 83
6. Smart RG Crack cocaine use: a review of prevalence and adverse effects Am J Drug Alcohol Abuse 1991 17 1 13 26 2038981
7. Escobedo LG Ruttenber AJ Agocs MM Anda RF Wetli CV Emerging patterns of cocaine use and the epidemic of cocaine overdose deaths in Dade County, Florida Arch Pathol Lab Med 1991 115 9 900 905 1929786
8. Galduróz JCF D'Almeida V Carvalho V Carlini EA III Levantamento sobre o uso de drogas entre estudantes de 1º e 2º graus em 10 capitais brasileiras – 1993 CEBRID - Escola Paulista de Medicina 1993 1 81
9. Galduróz JCF Noto AR Carlini EA IV Levantamento sobre o uso de drogas entre estudantes de 1º e 2º graus em 10 capitais brasileiras – 1997 CEBRID - Escola Paulista de Medicina 1997 1 130
10. Andrade AG Queiroz S Vilaboim RCM Uso de álcool e drogas entre alunos de graduação da Universidade de São Paulo (1996) Rev ABP-APAL 1997 19 2 53 59
11. Departamento Estadual de Narcóticos (DENARC). São Paulo Relatório anual 1997 1 67
12. Bucher RE Totugui ML Conocimiento y uso de drogas entre alumnos de Brasília. [Drugs: knowledge and use among students in Brasília] Acta Psiquiatr Psicol Am Lat 1988 34 2 113 126 3265572
13. Castel S Malbergier A. Farmacodependências: estudo comparativo de uma população atendida em serviço especializado: 1984-1988. [Psychoactive substance dependence: comparative analysis of a population attended at a specialist service: 1984-1988] Rev ABP-APAL 1989 11 3 126 132
14. Cardim MS Morgado AF Azevedo BA Drogas: aspectos familiares e diagnóstico [Drugs: familial and diagnostic aspects]. Rev ABP-APAL 1988 11 2 62 68
15. Gaensler EA Wright GW Evaluation of respiratory impairment Arch Environ Health 1966 12 2 146 189 5322533
16. Dean RA Harper ET Dumaual N Stoeckel DA Bosron WF Effects of ethanol on cocaine metabolism: formation of cocaethylene and norcocaethylene Toxicol Appl Pharmacol 1992 117 1 1 8 1440602
17. Farré M de la Torre R Llorente M Lamas X Ugena B Segura J Camí J. Alcohol and cocaine interactions in humans J Pharmacol Exp Ther 1993 266 3 1364 1373 8371143
18. Tardiff K Marzuk PM Leon AC Cocaine, opiates, and ethanol in homicides in New York City: 1990 and 1991 J Forensic Sci 1995 40 3 387 390 7782745
19. Grant BF Harford TC Concurrent and simultaneous use of alcohol with cocaine: results of national survey Drug Alcohol Depend 1990 25 1 97 104 2323315
20. Perez-Reyes M Jeffcoat AR Ethanol/cocaine interaction cocaine and cocaethylene plasma concentrations and their relationship to subjective and cardiovascular effects Life Sci 1992 51 8 553 563 1640806
21. Bunn WH Giannini AJ Cardiovascular complications of cocaine abuse Am Fam Physician 1992 46 3 769 773 1387505
22. Tardiff K Gross E Wu J Stajic M Millman R. Analysis of cocaine-positive fatalities J Forensic Sci 1989 34 1 53 63 2918288
23. Muñoz DR Souza MB Yen CC Leyton V Silva OA Verificação da presença de álcool, canabinoides e cocaína em vítimas de morte violenta XV Congresso Brasileiro de Medicina Legal 1998, Sep 9-13 Salvador, Brazil 15 15
24. Toledo FCP Silva AO Leyton V Detection of benzoylecgonine in hair of cocaine users using fluorescence polarization immunoassay 2nd European Meeting on Hair Analysis. Program and Abstracts. Society of Hair Testing 1999, Jun 14-16 Martigny, Switzerland 4 4
25. Maldonado AL De Albornoz EOC Drogas de abuso Masson AS Medicina legal y toxicología 5.a Barcelona MASSON 1998 892 907
26. Regan TJ Alcohol and the cardiovascular system JAMA 1990 264 3 377 381 2194048
27. Benowitz NL Clinical pharmacology and toxicology of cocaine Pharmacol Toxicol 1993 72 1 3 12
28. Madden JA Powers RH Effect of cocaine and cocaine metabolites on cerebral arteries in vitro Life Sci 1990 47 13 1109 1114 2233129
29. Seale TW Genetic differences in response to cocaine and stimulant drugsIn: Crabbe JC Jr, Harris RA The genetics basis of alcohol and drug actions New York Plenum Press 1991 295 321
30. Warner EA Kosten TR O'Connor PG Pharmacotherapy for opioid and cocaine abuse Med Clin North Am 1997 81 4 909 925 9222260
31. Foltin RW Fischman MW Smoked and intravenous cocaine in humans: acute tolerance, cardiovascular and subjective effects J Pharmacol Exp Ther 1991 257 1 247 261 2019989
32. Chasin AAM Mídio AF. Aspecto toxicológico da overdose de cocaína [Toxicology of cocaine overdose] Rev Farm Bioquim Univ São Paulo 1991 27 1 1 27
33. Laposata EA Mayo GL A review of pulmonary pathology and mechanisms associated with inhalation of freebase cocaine (crack) Am J Forensic Med Pathol 1993 14 1 1 9 8493959
34. Petersen RC A history of cocaine Petersen RC Stilman RC Cocaine Monograph 13 Washington DC National Institute of Drug Abuse 1977 1 16
35. Jentzen J. Medical complications of cocaine abuse Am J Clin Pathol 1993 100 5 475 476 8249883
36. Thadani PV NIDA conference report on cardiopulmonary complications of "crack" cocaine use Clinical manifestations and pathophysiology. Chest 1996 110 4 1072 1076 8874270
37. Khalsa ME Tashkin DP Perrochet B. Smoked cocaine: patterns of use and pulmonary consequences J Psychoactive Drugs 1992 24 3 265 272 1432405
38. Heffner JE Harley RA Schabel SI Reações pulmonares devidas ao abuso de drogas ilícitas Cooper JAB Clínicas de doenças pulmonares Rio de Janeiro Interlivros 1990 151 159
39. Jeffcoat AR Perez-Reyes M Hill JM Sadler BM Cook CE Cocaine disposition in humans after intravenous injection, nasal insufflation (snorting), or smoking Drug Metab Dispos 1989 17 2 153 159 2565204
40. Tashkin DP Khalsa ME Gorelick D Pulmonary status of habitual cocaine smokers Am Rev Respir Dis 1992 145 1 92 100 1731605
41. Haim DY Lippmann ML Goldberg SK Walkenstein MD The pulmonary complications of crack cocaine. A comprehensive review Chest 1995 107 1 233 240 7813284
42. Calabuig JAG Los grandes síndromes toxicológicos Masson AS Medicina legal y toxicología 5a ed. Barcelona Masson 1998 629 648
43. Cooper CB Bai TR Heyderman E Cellulose granuloma in the lungs of a cocaine sniffer Br Med J (Clin Res Ed) 1983 286 6383 2021 2022
44. Oubeid M Bickel JT Ingram EA Scott GC Pulmonary talc granulomatosis in a cocaine sniffer Chest 1990 98 1 237 239 2361397
45. Shesser R Davis C Edelstein S. Pneumomediastinum and pneumothorax after inhaling alkaloidal cocaine Ann Emerg Med 1981 10 4 213 215 7224267
46. Aroesty DJ Stanley RB Crockett DM Pneumomediastinum and cervical emphysema from the inhalation of "free based" cocaine: Report of three cases Otolaryngol Head Neck Surg 1986 94 3 372 374 3083368
47. Eurman DW Potash HI Eyler WR Paganussi PJ Beute GH Chest pain and dyspnea related to "crack" cocaine smoking: value of chest radiography Radiology 1989 172 2 459 462 2748826
48. Leitman BS Greengart A Wasser HJ Pneumomediastinum and pneumopericardium after cocaine abuse Am J Roentgenol 1988 151 3 614 614
49. Ettinger NA Albin RJ A review of the respiratory effects of smoking cocaine Am J Med 1989 87 6 664 668 2686434
50. Gurney JW Bates FT Pulmonary cystic disease: comparison of Pneumocystis carinii pneumatoceles and bullous emphysema due to intravenous drug abuse Radiology 1989 173 1 27 31 2789412
51. Cucco RA Yoo OH Cregler L Chang JC Nonfatal pulmonary edema after "freebase" cocaine smoking Am Rev Respir Dis 1987 136 1 179 181 3605832
52. Hoffman CK Goodman PC Pulmonary edema in cocaine smokers Radiology 1989 172 2 463 465 2748827
53. Kissner DG Lawrence WD Selis JE Flint A. Crack lung: pulmonary disease caused by cocaine abuse Am Rev Respir Dis 1987 136 5 1250 1252 3674585
54. Rebhun J. Association of asthma and freebase smoking Ann Allergy 1988 60 4 339 342 3358539
55. Rubin RB Neugarten J. Cocaine associated asthma Am J Med 1990 88 4 438 439 2327429
56. Godwin JE Harley RA Miller KS Heffner JE Cocaine, pulmonary hemorrhage, and hemoptysis Ann Intern Med 1989 110 10 843 843
57. Murray RJ Smialek JE Golle M Albin RJ Pulmonary artery medial hypertrophy in cocaine users without foreign particle microembolization Chest 1989 96 5 1050 1053 2805835
58. Walek JW Masson RG Siddiqui M. Pulmonary hemorrhage in a cocaine abuser Chest 1989 96 1 222 222
59. Murray RJ Albin RJ Mergner W Criner GJ Diffuse alveolar hemorrhage temporally related to cocaine smoking Chest 1988 93 2 427 429 3338316
60. Bouchi J el Asmar B Couetil JP Gédéon E Bouchi N. Hémorragie alvéolaire après inhalation de cocaïne. [Alveolar hemorrhage after cocaine inhalation] Presse Med 1992 21 22 1025 1026 1387216
61. Bailey ME Fraire AE Greenberg SD Barnard J Cagle PT Pulmonary histopathology in cocaine abusers Hum Pathol 1994 25 2 203 207 8119721
62. O'Donnell AE Mappin FG Sebo TJ Tazelaar H. Interstitial pneumonitis associated with "crack" cocaine abuse Chest 1991 100 4 1155 1157 1914578
63. Byers JM Soin JS Fisher RS Hutchins GM Acute pulmonary alveolitis in narcotics abuse Arch Pathol 1975 99 5 273 277 1093538
64. Patel RC Dutta D Schonfeld SA Free-base cocaine use associated with bronchiolitis obliterans organizing pneumonia Ann Intern Med 1987 107 2 186 187 3605899
65. Citron BP Halpern M McCarron M Lundberg GD McCormick R Pincus IJ Tatter D Haverback BJ Necrotizing angiitis associated with drug abuse N Engl J Med 1970 283 19 1003 1011 4394271
66. Angiitis in drug abusers N Engl J Med 1971 284 2 111 313 4395137
67. Merkel PA Koroshetz WJ Irizarry MC Cudkowicz ME Cocaine-associated cerebral vasculitis Semin Arthritis Rheum 1995 25 3 172 183 8650587
68. Brust JC Vasculitis owing to substance abuse Neurol Clin 1997 15 4 945 957 9367974
69. Orriols R Muñoz X Ferrer J Huget P Morell F. Cocaine-induced Churg-Strauss vasculitis Eur Respir J 1996 9 1 175 177 8834352
70. Armstrong M Shikani AH Nasal septal necrosis mimicking Wegener's granulomatosis in a cocaine abuser Ear Nose Throat J 1996 75 9 623 626 8870370
71. Yakel DL Eisenberg MJ Pulmonary artery hypertension in chronic intravenous cocaine users Am Heart J 1995 130 2 398 399 7631626
72. Tomashefski JF Hirsch CS The pulmonary vascular lesions of intravenous drug abuse Hum Pathol 1980 11 2 133 145 7399505
73. Talebzadeh VC Chevrolet JC Chatelain P Helfer C Cox JN Myocardite à éosinophiles et hypertension pulmonaire chez une toxicomane. Etude anatomo-clinique et brève revue de la littérature. [Eosinophilic myocarditis and pulmonary hypertension in a drug addict. Anatomoclinical study and brief review of the literature] Ann Pathol 1990 10 1 40 46 2183808
74. Kleerup EC Wong M Marques-Magallanes JA Goldman MD Tashkin DP Acute effects of intravenous cocaine on pulmonary artery pressure and cardiac index in habitual crack smokers Chest 1997 111 1 30 35 8995989
75. Fligiel SE Roth MD Kleerup EC Barsky SH Simmons MS Tashkin DP Tracheobronchial histopathology in habitual smokers of cocaine, marijuana, and/or tobacco Chest 1997 112 2 319 326 9266864
76. Forrester JM Steele AW Waldron JA Parsons PE Crack lung: an acute pulmonary syndrome with a spectrum of clinical and histopathological findings Am Rev Respir Dis 1990 142 2 462 467 2382909
77. Tashkin DP Simmons MS Coulson AH Clark VA Gong H. Respiratory effects of cocaine "freebasing" among habitual users of marijuana with or without tobacco Chest 1987 92 4 638 644 3652749
78. Goldberg RE Lipuma JP Cohen AM Pneumomediastinum associated with cocaine abuse: a case report and review of the literature J Thorac Imaging 1987 2 3 88 89 3612924
79. Klinger JR Bensadoun E Corrao WM Pulmonary complications from alveolar accumulation of carbonaceous material in a cocaine smoker Chest 1992 101 4 1171 1173 1555446
80. Tashkin DP Kleerup EC Koyal SN Marques JA Goldman MD Acute effects of inhaled and i.v. cocaine on airways dynamics Chest 1996 110 4 904 910 8874243
81. Suhl J Gorelick DA Pulmonary function in male cocaine smokers Am Rev Respir Dis 1998 137 A448 A448
82. Del Bono EA O'Brien K Murphy RLH Jr. Lung sound abnormalities in cocaine freebasers Substance abuse 1989 10 A201 A201
83. Itkonen J Schnoll S Glassroth J. Pulmonary dysfunction in "freebase" cocaine users Arch Intern Med 1984 144 11 2195 2197 6437355
84. Weiss RD Goldenheim PD Mirin SM Hales CA Mendelson JH Pulmonary dysfunction in cocaine smokers Am J Psychiatry 1981 138 8 1110 1112 6789686
85. Tashkin DP What is the true impact of crack on the lung? Chest 1995 108 4 1180 1181
86. Goldbaum TS Yen CC Santos UP Noritomi DT Terra Filho M. Alterações pulmonares em usuários crônicos de cocaína – Estudo preliminar J Pneumol 1998 24 1 S99 S99
87. Adrouny A Magnusson P. Pneumopericardium from cocaine inhalation N Engl J Med 1985 313 1 48 49
88. Yen CC Santos UP Leite M Capellozi VL Terra Filho M. Alterações tomográficas e anátomopatológicas em usuários de cocaína J Pneumol 1998 24 1 S114 S114
89. Susskind H Weber DA Volkow ND Hitzemann R. Increased lung permeability following long-term use of free-base cocaine (crack) Chest 1991 100 4 903 909 1914604
90. Tashkin DP Kleerup EC Hoh CK Kim KJ Webber MM Gil E. Effects of "crack" cocaine on pulmonary alveolar permeability Chest 1997 112 2 327 335 9266865
91. Terra-Filho M Yen CC Leite MC Andrade AG Santos UP Goldbaum TS Soares Junior J Meneghetti JC Inflammatory disease assessed by Gallium-67 lung scan in illicit drugs (cocaine/marijuana) users (IDU) in São Paulo Brazil Amer J Respir Crit Care Med 1999 159 3 A621 A621
92. Tashkin DP Pulmonary complications of smoked substance abuse West J Med 1990 152 5 525 530 2190420
93. Mao JT Zhu LX Sharma S Cocaine inhibits human endothelial cell IL-8 production: the role of transforming growth factor-beta Cell Immunol 1997 181 1 38 43 9344494
94. Baldwin GC Buckley DM Roth MD Kleerup EC Tashkin DP Acute activation of circulating polymorphonuclear neutrophils following in vivo administration of cocaine. A potential etiology for pulmonary injury Chest 1997 111 3 698 705 9118711
